NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
4.31
Dollar change
-0.08
Percentage change
-1.82
%
Index- P/E- EPS (ttm)-13.26 Insider Own7.84% Shs Outstand8.57M Perf Week-0.46%
Market Cap37.24M Forward P/E- EPS next Y-3.79 Insider Trans-5.58% Shs Float7.96M Perf Month-4.86%
Enterprise Value154.00M PEG- EPS next Q-4.24 Inst Own50.13% Short Float25.41% Perf Quarter3.61%
Income-62.52M P/S0.26 EPS this Y21.36% Inst Trans-10.42% Short Ratio21.70 Perf Half Y-51.71%
Sales142.13M P/B- EPS next Y65.43% ROA-37.64% Short Interest2.02M Perf YTD-57.51%
Book/sh-24.03 P/C0.53 EPS next 5Y47.98% ROE- 52W High16.95 -74.57% Perf Year-71.13%
Cash/sh8.09 P/FCF- EPS past 3/5Y27.56% 27.91% ROIC- 52W Low3.51 22.79% Perf 3Y-94.40%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-11.54% 28.85% Gross Margin95.97% Volatility6.73% 7.34% Perf 5Y-98.54%
Dividend TTM- EV/Sales1.08 EPS Y/Y TTM61.65% Oper. Margin-83.69% ATR (14)0.35 Perf 10Y-98.97%
Dividend Ex-Date- Quick Ratio1.28 Sales Y/Y TTM1.19% Profit Margin-43.99% RSI (14)42.77 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio1.33 EPS Q/Q42.94% SMA20-1.63% Beta0.25 Target Price23.25
Payout- Debt/Eq- Sales Q/Q-9.39% SMA50-15.63% Rel Volume0.81 Prev Close4.39
Employees279 LT Debt/Eq- EarningsMay 12 AMC SMA200-50.60% Avg Volume93.20K Price4.31
IPONov 06, 2013 Option/ShortYes / Yes EPS/Sales Surpr.37.32% -14.53% Trades Volume75,082 Change-1.82%
Date Action Analyst Rating Change Price Target Change
Jan-19-23Initiated Piper Sandler Overweight $8
Nov-04-22Upgrade RBC Capital Mkts Sector Perform → Outperform $7 → $10
Feb-09-22Upgrade JP Morgan Underweight → Neutral $8
Nov-19-21Resumed Morgan Stanley Equal-Weight $27 → $10
Aug-06-21Downgrade SVB Leerink Outperform → Mkt Perform $6
Aug-06-21Downgrade RBC Capital Mkts Outperform → Sector Perform $17 → $8
Aug-06-21Downgrade JP Morgan Overweight → Neutral
Jul-02-20Initiated Morgan Stanley Overweight $34
Mar-04-20Initiated Barclays Overweight $30
Jan-17-20Downgrade Wedbush Outperform → Neutral
Jun-03-25 08:00AM
Jun-02-25 04:05PM
May-26-25 09:55AM
May-19-25 09:55AM
07:00AM
09:31AM Loading…
May-14-25 09:31AM
May-13-25 03:08AM
May-12-25 05:25PM
04:26PM
04:05PM
May-08-25 04:05PM
May-05-25 05:10PM
May-01-25 04:05PM
Apr-01-25 04:05PM
11:50AM
04:05PM Loading…
Mar-03-25 04:05PM
Feb-24-25 08:40AM
Feb-20-25 02:03AM
01:39AM
Feb-19-25 11:45AM
08:40AM
07:45AM
07:30AM
04:59AM
Feb-12-25 07:00AM
Feb-03-25 04:05PM
Jan-13-25 08:30AM
Jan-07-25 09:28AM
Jan-02-25 04:05PM
07:00AM
08:00AM Loading…
Dec-09-24 08:00AM
Dec-03-24 07:00AM
Dec-02-24 07:00AM
Nov-25-24 07:00AM
Nov-20-24 04:05PM
Nov-18-24 07:00AM
Nov-06-24 02:08AM
Nov-05-24 07:30PM
12:45PM
08:40AM
07:37AM
07:30AM
Nov-04-24 07:14AM
Nov-01-24 04:05PM
Oct-31-24 10:02AM
08:00AM
07:30AM
Oct-30-24 04:30PM
Oct-25-24 01:01PM
Oct-17-24 10:35PM
Oct-01-24 04:05PM
Sep-23-24 05:00AM
Sep-05-24 09:35AM
Sep-03-24 04:05PM
07:00AM
Sep-02-24 05:52AM
Aug-07-24 02:56AM
Aug-06-24 10:30PM
09:25AM
08:21AM
07:30AM
Aug-01-24 04:05PM
Jul-31-24 04:05PM
Jul-24-24 11:24PM
Jul-15-24 10:56AM
Jul-05-24 09:10AM
Jul-01-24 04:05PM
Jun-26-24 04:42AM
Jun-03-24 04:05PM
Jun-01-24 01:45PM
May-29-24 04:05PM
May-23-24 06:45AM
May-09-24 11:10AM
03:02AM
May-08-24 10:36PM
04:45PM
04:05PM
12:54PM
09:12AM
07:41AM
07:30AM
07:30AM
May-02-24 04:30PM
May-01-24 04:05PM
Apr-24-24 04:01PM
Apr-01-24 04:05PM
Mar-06-24 04:05PM
Mar-04-24 11:53PM
Mar-01-24 04:05PM
09:21AM
Feb-29-24 10:03PM
06:15PM
08:40AM
07:50AM
07:30AM
Feb-25-24 01:37PM
Feb-22-24 07:00AM
Feb-14-24 10:00AM
Feb-01-24 04:05PM
Jan-08-24 08:30AM
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Paulson Richard A.President and CEOMay 06 '25Sale7.122361,68082,503May 07 05:03 PM
Rangwala ReshmaEVP & Chief Medical OfficerApr 23 '25Sale6.174192,58528,853Apr 24 04:40 PM
Paulson Richard A.President and CEOApr 04 '25Sale3.7424591682,739Apr 07 04:59 PM
Cheng Sohanya RoshanEVP & Chief Commercial OfficerMar 04 '25Sale6.293,44521,66934,314Mar 06 04:27 PM
Paulson Richard A.President and CEOMar 04 '25Sale6.2911,69473,55582,984Mar 06 04:27 PM
Rangwala ReshmaEVP & Chief Medical OfficerMar 04 '25Sale6.293,58722,56229,272Mar 06 04:26 PM
Poulton StuartEVP, Chief Development OfficerMar 04 '25Sale6.293,54822,31727,414Mar 06 04:24 PM
Mano MichaelSVP, General Counsel&SecretaryMar 04 '25Sale6.292,79317,56821,047Mar 06 04:13 PM
Poulton StuartEVP, Chief Development OfficerFeb 18 '25Sale0.635,9143,726320,714Feb 19 04:17 PM
Paulson Richard A.President and CEOFeb 04 '25Sale0.654,0992,6641,120,158Feb 05 04:16 PM
Paulson Richard A.President and CEOJan 06 '25Sale0.784,0553,1751,124,257Jan 07 04:03 PM
Paulson Richard A.President and CEODec 04 '24Sale0.813,6202,9321,128,312Dec 05 04:15 PM
Paulson Richard A.President and CEONov 05 '24Sale0.913,6753,3461,131,932Nov 06 04:06 PM
Paulson Richard A.President and CEOOct 04 '24Sale0.883,6073,1721,135,607Oct 07 04:44 PM
Mano MichaelSVP, General Counsel&SecretarySep 04 '24Sale0.723,9712,866273,881Sep 05 04:28 PM
Paulson Richard A.President and CEOSep 04 '24Sale0.723,6672,6471,139,214Sep 05 04:26 PM
Mason MichaelEVP, CFO & TreasurerSep 04 '24Sale0.727,0505,089391,054Sep 05 04:24 PM
Cheng Sohanya RoshanEVP & Chief Commercial OfficerSep 04 '24Sale0.725,3563,866404,051Sep 05 04:13 PM
Paulson Richard A.President and CEOAug 06 '24Sale0.933,6083,3551,142,881Aug 08 04:31 PM
Poulton StuartEVP, Chief Development OfficerJul 30 '24Sale1.062,8833,056326,628Jul 31 04:14 PM
Paulson Richard A.President and CEOJul 05 '24Sale0.853,6163,0771,146,489Jul 09 04:15 PM